WTAP
WTAP (WT1 associated protein, also known as KIAA0105, MGC3925 and Mum2) is a nuclear protein that associates with the m6A methyltransferase machinery and regulates mRNA splicing. It was first described through its interaction with the Wilms tumour suppressor WT1. Browse Assay Genie's current range of WTAP research reagents below, or read on for the biology behind the target.
WTAP is an associated component of the WMM complex, which mediates N6-methyladenosine (m6A) methylation of RNA. This modification influences the efficiency of mRNA splicing and RNA processing. WTAP is required for METTL3 and METTL14 to accumulate at nuclear speckles, and it acts as an mRNA splicing regulator. It also regulates the G2/M cell-cycle transition by binding the 3' UTR of CCNA2, which enhances the stability of that transcript.
The WTAP gene encodes a ubiquitously expressed nuclear protein. Like WT1, it is localised throughout the nucleoplasm and in nuclear speckles, where it partially colocalises with splicing factors. UniProt also records a cytoplasmic location. WTAP impairs the DNA-binding ability of WT1 and inhibits expression of WT1 target genes. Alternative splicing of the WTAP gene produces several transcript variants that encode three different isoforms. The protein belongs to the fl(2)d family, and the mouse ortholog is Wtap.
The name reflects its discovery as a partner of the Wilms tumour suppressor gene product WT1, which appears to act in both transcriptional and post-transcriptional regulation of certain cellular genes. HGNC places WTAP in the m6A methyltransferase complex and WTAP complex gene groups. Researchers studying WTAP often use a WTAP antibody, WTAP ELISA kit or WTAP protein reagent to examine its expression, localisation and role in RNA modification.
WTAP is a component of the WMM complex that mediates m6A methylation of RNA, making it central to studies of epitranscriptomic regulation.
WTAP acts as an mRNA splicing regulator and partially colocalises with splicing factors in nuclear speckles.
WTAP regulates the G2/M transition by binding the CCNA2 3' UTR and enhancing transcript stability.
WTAP binds WT1, impairs its DNA binding and inhibits expression of WT1 target genes.
WTAP is an associated component of the WMM complex that mediates m6A methylation of RNA. It is required for METTL3 and METTL14 to accumulate at nuclear speckles, regulates mRNA splicing, and promotes G2/M transition by stabilising CCNA2 mRNA through its 3' UTR.
WTAP is also called KIAA0105, MGC3925 and Mum2, and was previously named Wilms tumour 1 associated protein. UniProt lists the protein as Pre-mRNA-splicing regulator WTAP. Alternative splicing of the gene gives several transcript variants encoding three different isoforms.
WTAP was identified as a WT1-associating protein. It impairs the DNA-binding ability of WT1 and inhibits expression of WT1 target genes. Like WT1, it localises through the nucleoplasm and in speckles. The mouse ortholog is Wtap; check the datasheet of any product for its validated reactivity.
Other m6A methyltransferase complex components, splicing regulators and cell-cycle proteins linked to WTAP biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15007; product specifications from Assay Genie datasheets.